HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nanotech Web site

This article was originally published in The Rose Sheet

Executive Summary

Nanotechnology Consumer Products Inventory is "the first and only publicly accessible online inventory of nanotechnology consumer products," including items like creams and sunscreens, The Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars says. Unveiled March 10, inventory, which features information on 212 manufacturer-identified nano products, is available at Nanotechproject.org/consumerproducts. According to the project, there are 31 cosmetic products on the market containing nanotechnology. "The U.S. is the overwhelming leader in consumer nanotechnology product development with 126; East Asia and Europe follow with 42 and 35 nano products respectively," the group found...

You may also be interested in...



Health Products Lead Rapidly Expanding Nanotechnology Product List

Health & fitness products including cosmetics and personal-care items dominate the landscape of nano-engineered consumer goods, according to the Project on Emerging Nanotechnologies, overseen by the Woodrow Wilson International Center for Scholars

Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics

CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.

Adalvo Hails First European Launch Of Prolonged-Release Pregabalin

After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel